is metformin a glp-1 receptor agonist Immune system and insulin, metformin, SGLT2 and action. AMPK Diagram summarizing how metformin, gliclazide,
Description
World Health Organization, Obesity and overweight. June 9, 2021

Because thermoneutrality minimizes the contribution of non-shivering thermogenesis to whole-body energy expenditure and because non-shivering thermogenesis requires functional brown adipose tissue (BAT) [775], these data imply a contribution of endogenous GLP-1R signaling to the control of energy expenditure, at least in diet-induced obese mice, by regulating BAT activity

Oral, T.K

98.Dong N, Zhu C, Jiang J, Huang D, Li X, Quan G, et al

In comparison, when looking at GLP-1s, research suggests that people tend to put the weight back when they stop taking their medications, with just 39% of the weight lost sustained at one year after medical treatment has been stopped

Effect of exenatide on the steady-state pharmacokinetics of digoxin
